H1-antihistamines for chronic spontaneous urticaria

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 5, 2014, Pages

  Sharma, Maulina ^a   Bennett, Cathy ^b   Cohen, Stuart N ^c   Carter, Ben ^d  

^a DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b Faculty of Engineering and Computing   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; DESLORATADINE; EBASTINE; EMEDASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; LEVOCETIRIZINE; LORATADINE; MIZOLASTINE; PHENIRAMINE; RUPATADINE; CYPROHEPTADINE;

CHRONIC URTICARIA; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; URTICARIA;

CETIRIZINE; CYPROHEPTADINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROXYZINE; LORATADINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URTICARIA;

EID: 84923062871     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006137.pub2     Document Type: Review

References (312)

1. Alomar A, Puig L, De Moragas JM. Cetirizine in the treatment of chronic urticaria [Tratamiento de la urticaria cronica con dihidrocloruro de cetirizina]. Actas Dermo-Sifiliograficas 1990;81(3):181-3. [EMBASE: 1990175012]2757706
2. Anuradha P, Maiti R, Jyothirmai J, Mujeebuddin O, Anuradha M. Loratadine versus levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety. Indian Journal of Pharmacology 2010; Vol. 42, issue 1:12-6. [MEDLINE: 20606830]2757708
3. Beck HI, Cramers M, Herlin T, Sondergaard I, Zachariae H. Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study. Dermatologica 1985;171(1):49-51. [MEDLINE: 2863185]2757710
4. Belaich S, Bruttmann G, DeGreef H, Lachapelle J M, Paul E, Pedrali P, et al. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Annals of Allergy 1990;64(2 Pt 2):191-4. [MEDLINE: 1967919]2757712
5. Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. Journal of the American Academy of Dermatology 1995;33(2 Pt 1):192-8. [MEDLINE: 7622644]2757714
6. Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Annals of Pharmacotherapy 1996;30(10):1075-9. [MEDLINE: 8893110]2757716
7. Bronsky E, Desloratadine urticaria study group. Desloratadine: a safe and effective therapy for chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology 2001;86:109. [CENTRAL: CN-00384995]2757718
8. Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 1996;51(5):320-5. [MEDLINE: 8836336]2757720
9. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria: a randomized double-blind study. British Journal of Dermatology 1978;99(6):675-9. [MEDLINE: 367422]2757722
10. Dakhale GN, Shinde AT, Mahatme MS, Hiware SK, Mishra DB, Mukhi JI, et al. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial. International Journal of Dermatology 2014;53(5):643-9. [MEDLINE: 24320728]2757724
11. Degonda M, Pichler WJ, Bircher A, Helbling A. Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients. Schweizerische Rundschau für Medizin Praxis / Revue Suisse de Médecine Praxis 2002;91(15):637-43. [MEDLINE: 12014063]2757726
12. Di Lorenzo G, Pacor ML, Mansueto P, Esposito Pellitteri M, Lo Bianco C, Ditta V, et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. Journal of Allergy & Clinical Immunology 2004;114(3):619-25. [MEDLINE: 15356567]2757728
13. Dubertret L, Murrieta Aguttes M, Tonet J. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. Journal of the European Academy of Dermatology & Venereology 1999;12(1):16-24. [MEDLINE: 10188144]2757730
14. Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, et al. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. European Journal of Dermatology 2007;17(3):223-8. [MEDLINE: 17478385]2757732
15. Finn A, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCL in the treatment of chronic idiopathic urticaria CIU. Annals of Allergy, Asthma and Immunology 1999;85:118. [CENTRAL: CN-00278281]2757734
16. Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. Journal of Allergy & Clinical Immunology 1999;104(5):1071-8. [MEDLINE: 10550755]2757735
17. Gale AE, Harvey SG, Calthrop JG, Gibson JR. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria. Journal of International Medical Research 1989;17(Suppl 2):25B-7B. [MEDLINE: 2569998]2757737
18. Garavaglia M, Cavallo A, Goncalvez M, Cassanitti C. Double-blind, comparative, six weeks in duration study to evaluate the efficacy and tolerability of cetirizine vs terfinadine and placebo in the treatment of patients with chronic idiopathic urticaria [Estudio doble ciego, comparativo, de seis semanas de duracion para evaluar la eficacia y tolerancia de la cetirizina vs terfinadina y placebo en el tratamiento de pacientes con urticaria idiopatica cronica]. Archivos Argentinos de Alergia e Immunologia Clinica 1995;26(3):179-89. 2757739
19. Ghosh S, Haldar S. Therapeutic effect of doxepin in chronic idiopathic urticaria. Indian Journal of Dermatology, Venerology & Leprology 1990; Vol. 56, issue 3:218-20. [EMBASE: 1990321412]2757741
20. Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, et al. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 2007;62(5):539-46. [MEDLINE: 17441794]2757743
21. Go MJTH, Wuite J, Arendt C, Bernheim J. Double-blind, placebo controlled comparison of cetirizine and terfenadine in chronic idiopathic urticaria. Acta Therapeutica 1989;15(1):77-86. [EMBASE: 1989116427]2757745
22. Godse K, Jain A, Pharande P. Comparative efficacy of fexofenadine and levocetirizine in chronic idiopathic urticaria. Indian Journal of Dermatology 2007;52(4):212-3. [EMBASE: 2008015145]2757747
23. Goh CL, Wong WK, Lim J. Cetirizine vs placebo in chronic idiopathic urticaria-a double blind randomised cross-over study. Annals of the Academy of Medicine, Singapore 1991;20(3):328-30. [MEDLINE: 1681778]2757749
24. Grant JA, Bernstein DI, Buckley CE, Chu T, Fox RW, Rocklin RE, et al. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. Journal of Allergy & Clinical Immunology 1988;81(3):574-9. [MEDLINE: 3126220]2757751
25. Gu J, Wen H, Hu ZJ, Lian S, Guo ZL, Hou J. A study on the efficacy and safety of desloratadine in the treatment of chronic idiopathic urticaria. Chinese Journal of Dermatovenereology 2002;16(4):227-9. [CENTRAL: CN-00430184]2757753
26. Guo ZP, Zhang YZ, Chen Y Xiong L, Jiang X, Zhang M, Li Z. Randomized double blind research of mizolastine for the treatment of idiopathic chronic urticaria. West China Medical Journal 2003;18(4):482-3. [CENTRAL: CN-00517791]2757755
27. Handa S, Dogra S, Kumar B. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. Journal of Dermatological Treatment 2004;15(1):55-7. [MEDLINE: 14754652]2757757
28. Hao F, Peng ZH, Chen XP, Bi J, Hi G, Diao Q, et al. A multiple-centre double-blind comparative clinical trial of desloratadine and loratadine for the treatment of chronic idiopathetic urticaria. Chinese Journal of Dermatovenereology 2003;17(4):233-5. [CENTRAL: CN-00493820]2757759
29. Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. Journal of Allergy & Clinical Immunology 1981;68(4):262-6. [MEDLINE: 6116728]2757761
30. Hjorth N. Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. Cutis 1988;42(4A):29-30. [MEDLINE: 2903817]2757763
31. Hoxha, M, Xhani A, Shehu E, Shameti A, Qirko E, Priftanji A. The treatment of severe urticaria with increasing doses of antihistamines [Abstract]. 30th Congress of the European Academy of Allergy and Clinical Immunology Istanbul Turkey. Conference Start: 20110611 Conference End: 20110615. Allergy: European Journal of Allergy and Clinical Immunology 2011;66:272-3. [EMBASE: 70641059]2757765
32. Juhlin L, Gibson JR, Harvey SG, Huson LW. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study. International Journal of Dermatology 1987;26(10):653-4. [MEDLINE: 2892806]2757767
33. Juhlin L. Cetirizine in the treatment of chronic urticaria. Clinical Therapeutics 1991;13(1):81-6. [MEDLINE: 1827614]2757769
34. Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. Journal of Allergy & Clinical Immunology 1990;86(6 Pt 2):1014-8. [MEDLINE: 1979796]2757771
35. Kaplan AP, Spector SL, Meeves S, Liao Y, Varghese ST, Georges G. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Annals of Allergy, Asthma & Immunology 2005;94(6):662-9. [MEDLINE: 15984599]2757773
36. Spector SL, Shikiar R, Harding G, Meeves S, Leahy MJ. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis 2007;79(2):157-62. [MEDLINE: 17388220]2757774
37. Kint A, Constandt L, Arendt C, Bernheim J. Comparative efficacy of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Acta Therapeutica 1989;15(1):65-75. [EMBASE: 1989116426]2757776
38. Leyh F, Harvey SG, Gibson JR, Manna VK. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria. Journal of International Medical Research 1989;17(Suppl 2):22B-4B. [MEDLINE: 2569997]2757778
39. Leynadier F, Duarte-Risselin C, Murrieta M. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR Study Group. European Journal of Dermatology 2000;10(3):205-11. [MEDLINE: 10725819]2757780
40. Liu LL, Zhu XJ, Jiang W, Chen XX, Li M, Peng Z, et al. A multicentre, double-blind, randomized, parallel comparative study on the efficacy and safety of mizolastine versus loratadine in the treatment of chronic urticaria. Chinese Journal of Dermatology 2003;36(6):306-9. [CENTRAL: CN-00484864]2757782
41. Liu HN, Pan LM, Hwang SC, Chu TL. Nifedipine for the treatment of chronic urticaria: a double-blind cross-over study. Journal of Dermatological Treatment 1990;1(4):187-9. [EMBASE: 1990343405]2757784
42. Locci F, Del Giacco GS. Treatment of chronic idiopathic urticaria with topical preparations: controlled study of oxatomide gel versus dechlorpheniramine cream. Drugs Under Experimental & Clinical Research 1991;17(8):399-403. [MEDLINE: 1688044]2757786
43. Maiti R, Jaida J, Raghavendra BN, Goud P, Ahmed I, Palani A. Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety. Journal of Drugs in Dermatology 2011; Vol. 10, issue 12:1444-50. [MEDLINE: 22134570]2757788
44. Makino T, Takegami Y, Rehman MU, Yoshihisa Y, Ishida W, Toyomoto T, et al. Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria. Clinical, Cosmetic and Investigational Dermatology CCID 2012; Vol. 5:141-6. [MEDLINE: 23055763]2757790
45. Marks R. Treatment of chronic urticaria [letter]. British Journal of Dermatology 1980;102(2):240. [MEDLINE: 6992835]2757792
46. Monroe E, Fox R, Green A. Efficacy and safety of loratadine (10 mg once and daily) in the management of idiopathic chronic urticaria [Abstract no:3]. Indian Journal of Dermatology, Venerology & Leprology 1989;55:270. [CENTRAL: CN-00692719]2757794
47. Monroe EW, Fox RW, Green AW, Izuno GT, Bernstein DI, Pleskow WW, et al. Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria. Journal of the American Academy of Dermatology 1988;19(1 Pt 1):138-9. [MEDLINE: 2900256]2757795
48. Monroe EW. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clinical Therapeutics 1992;14(1):17-21. [MEDLINE: 1349509]2757797
49. Monroe E, Finn A, Patel P, Guerrero R, Ratner P, Bernstein D. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. Journal of the American Academy of Dermatology 2003;48(4):535-41. [MEDLINE: 12664016]2757799
50. NCT00536380. A study of the efficacy, safety, and quality of life (QOL) in patients with chronic idiopathic urticaria dosed with AERIUS (desloratadine) tablets (5 mg, 10 mg, or 20 mg once daily)-ACCEL. NCT00536380. http://clinicaltrials.gov/show/NCT00536380. Accessed 3 July 2013. 2757801
51. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology 2000;84(5):517-22. [MEDLINE: 10831005]2757803
52. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clinical & Experimental Allergy 2004;34(9):1401-7. [MEDLINE: 15347373]2757805
53. Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. British Journal of Dermatology 2006;154(3):533-8. [MEDLINE: 16445787]2757807
54. Ollert MW, Brockow K, Engst R, Ring J. Successful treatment of chronic urticaria with mizolastine-Results of a placebo-controlled study [Erfolgreiche behandlung der chronischen urtikaria mit mizolastin-Ergebnisse einer plazebokontrollierten doppelblindstudie]. Allergo Journal 1999; Vol. 8, issue Suppl 1:S22-8. [EMBASE: 1999044749]2757809
55. Grob JJ, Stalder JF, Dreyfus I, Ortonne JP. Desloratadine improves quality of life and measures of impaired sleep and daily activity in chronic idiopathic urticaria [Abstract]. American Academy of Allergy Asthma and Immunology, San Francisco, California, March 19-23 2004. Journal of Allergy & Clinical Immunology 2004;113(2 Suppl):S28. [CENTRAL: CN-00475471]2757811
56. Ortonne JP, Dron Gonzalvez M, Brassac I, Guinnepain MT. Desloratadine has a rapid and enduring impact on signs and symptoms in chronic idiopathic urticaria [Abstract]. American Academy of Allergy Asthma and Immunology, San Francisco, California, March 19-23 2004. Journal of Allergy & Clinical Immunology 2004; Vol. 113, issue 2 Suppl:S135. [CENTRAL: CN-00476210]2757812
57. Grob JJ, Auquier P, Dreyfus I, Ortonne JP. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study. Journal of the European Academy of Dermatology & Venereology 2008;22(1):87-93. [PUBMED: 18181978]2757814
58. Ortonne JP, Grob JJ, Auquier P, Dreyfus I. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. American Journal of Clinical Dermatology 2007;8(1):37-42. [MEDLINE: 17298105]2757815
59. Patel P, Danzig M. Comparative efficacy and safety of loratadine and cetirizine in patients with chronic idiopathic urticaria. Advances in Therapy 1997; Vol. 14, issue 6:318-22. [EMBASE: 1998034759]2757817
60. Paul E, Berth Jones J, Ortonne JP, Stern M. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: a placebo-controlled, parallel-group, dose-ranging study. Journal of Dermatological Treatment 1998; Vol. 9, issue 3:143-9. [EMBASE: 1998346160]2757819
61. Peyri J, Vidal J, Marron J, Fonseca E, Suarez E, Ledo A, et al. Ebastine in chronic urticaria: a double-blind placebo-controlled study. Journal of Dermatological Treatment 1991;2(2):51-3. [EMBASE: 1991326012]2757821
62. Phanuphak P. Double-blind, placebo-controlled study of ketotifen in chronic urticaria. Immunology & Allergy Practice 1987;9(4):138-43. [EMBASE: 1987132488]2757823
63. Pons-Guiraud A, Nekam K, Lahovsky J, Costa A, Piacentini A. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial. European Journal of Dermatology 2006;16(6):649-54. [MEDLINE: 17229605]2757825
64. NCT00264303. CUTE (Chronic Urticaria Treatment Evaluation). //clinicaltrials.gov/show/NCT00264303 (accessed 3 July 2013). 2757827
65. Potter PC, Kapp A, Maurer M, Guillet G, Jian AM, Hauptmann P, et al. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy 2009; Vol. 64, issue 4:596-604. [MEDLINE: 19053988]2757828
66. Hein R, Gauger A, Rikken G, Staudinger H, Ring J. Rapid onset and sustained efficacy of desloratadine in treatment of chronic idiopathic urticaria. Allergologie 2000;23:427. [CENTRAL: CN-00606999]2757830
67. Prenner B, Desloratadine urticaria study group. Desloratadine has a rapid onset of action in the treatment of chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology 2001;86:84. [CENTRAL: CN-00385348]2757831
68. Ring J, Hein R, Gauger A, Bronsky E, Miller B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. International Journal of Dermatology 2001;40(1):72-6. [MEDLINE: 11277962]2757832
69. Salo OP, Harvey SG, Calthrop JG, Gibson JR. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria. Journal of International Medical Research 1989;17(Suppl 2):18B-21B. [MEDLINE: 2569996]2757834
70. Sener O, Taskapan O, Kalelioglu C, Ozanguc N. Efficacy of fluoxetine versus ketotifen in the treatment of chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology 1999;82:119. [CENTRAL: CN-00284498]2757836
71. Staevska MT, Gugutkova MD, Lazarova TC, Kralimarkova TZ, Dimitrov VD, Popov TA. Effect of two different drug regimens containing higher than conventional doses of levocetirizine in weaning urticaria patients from systemic corticosteroid treatment. Conference: European Academy of Allergy and Clinical Immunology and World Allergy Organization World Allergy and Asthma Congress 2013 Milan Italy. Conference Start: 20130622 Conference End: 20130622. Conference Publication:. Allergy: European Journal of Allergy and Clinical Immunology 2013;68(Suppl 97):189-336. 2757838
72. Staevska, M, Gugutkova M, Lazarova C, Kralimarkova T Dimitrov V, Zuberbier T, et al. Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. British Journal of Dermatology 2014;171(1):148-54. [MEDLINE: 24472058]2757839
73. Thompson A, Finn A, Schoenwetter W. Effect of 60 mg BID fexofenadine HCL on quality of life, work productivity, and regular activity in patients with chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology 1999;82:122. [CENTRAL: CN-00285038]2757841
74. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. Journal of the American Academy of Dermatology 2000;43(1 Pt 1):24-30. [MEDLINE: 10863219]2757842
75. Thompson A, Finn A, Schoenwetter W. Effect of 60 mg BID fexofenadine HCL on quality of life, work productivity, and regular activity in patients with chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology 1999; Vol. 82:122. [CENTRAL: CN-00285038]2757844
76. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. Journal of the American Academy of Dermatology 2000;43(1 Pt 1):24-30. [MEDLINE: 10863219]2757845
77. Wan KS. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. Journal of Dermatological Treatment 2009; Vol. 20, issue 4:194-7. [MEDLINE: 19085267]2757847
78. Wang HJ, Zhang JA, Yu JB. Clinical observation of long-term decrement mizolastine therapy in the treatment of chronic urticaria. Journal of Clinical Dermatology 2012; Vol. 41, issue 7:440-2. [EMBASE: 2012596086]2757849
79. Weller K, Ardelean E, Scholz E, Martus P, Zuberbier T, Maurer M. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. Acta Dermato-Venereologica 2013; Vol. 93, issue 2:168-74. [MEDLINE: 23053062]2757851
80. Wu S-X, Guo N-R, Chen J, Sun J-F. Different dosages of azelastine and in combination of cimetidine in the treatment of chronic urticaria. Journal of Clinical Dermatology 2008;37(3):194-6. [EMBASE: 2008197256]2757853
81. Yin R, Hao F, Xiang MM, Shun RS, Deng J. A clinical trial of levocetirizine in the treatment of chronic idiopathic urticaria. Journal of Clinical Dermatology 2003;32(8):477-8. 2757855
82. Yin R, Diao QC, Ye QY. Clinical research of three antihistamines in the treatment of chronic idiopathic urticaria. Journal of Clinical Dermatology 2003b;32(11):675-77. 2757857
83. Zou Y, Chen XP. Curative effect of desloratadine in the treatment of chronic idiopathic urticaria. Central China Medical Journal 2002;27(2):75-6. 2757859
84. Zuberbier T, Oanta A, Bogacka E, Medina I, Wesel F, Uhl P, et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. Allergy 2010; Vol. 65, issue 4:516-28. [MEDLINE: 19860762]2757861
85. Aberer W, Kränke B. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. Journal of the European Academy of Dermatology & Venereology 2001; Vol. 15, issue 1:77-9. [MEDLINE: 11451333]2757863
86. Abushareeah AM, Yousuf M, Decker LA, de Mahieu C. Double blind comparative study of cetirizine, mequitazine and placebo in the treatment of chronic idiopathic urticaria [Abstract 3211]. The 19th World Congress of Dermatology 15-20 June, 1997 Sydney, Australia. Australasian Journal of Dermatology 1997;38(Suppl 2):211. 2757865
87. Alomar A, De La Cuadra, Fernandez J. Cetirizine vs astemizole in the treatment of chronic idiopathic urticaria. Journal of International Medical Research 1990;18(5):358-65. [MEDLINE: 2147912]2757867
88. Andri L, Senna GE, Betteli C, Givanni S, Andri G, Lombardi C, et al. A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. Allergy 1993;48(5):358-65. [MEDLINE: 8368464]2757869
89. Anon. The steroid-sparing effect of astemizole in chronic urticaria [Chronische Urtikaria. Unter Astemizol-Therapie kann die Kortikosteroid-Dosis reduziert werden]. H+G Zeitschrift fur Hautkrankheiten 1992;67(9):820. [EMBASE: 1992296793]2757871
90. Anonymous. Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily. Allergy 1989;44(7):447-52. [MEDLINE: 2573286]2757873
91. Anonymous (Wan-Qing L). A double-blind clinical trial of astemizole in the treatment of chronic urticaria (Chinese). Chinese Journal of Dermatology 1990;26(3):120-1. 2757875
92. Anonymous. Acid casein and cyproheptadine in the treatment of 150 cases of chronic urticaria (Chinese). Chinese Journal of Dermatology 1992;25(4):263. 2757877
93. Arendt C, Bernheim J. Double-blind comparison of maintenance treatment of chronic idiopathic urticaria by cetirizine and terfenadine. Current Therapeutic Research Clinical and Experimental 1989;46(4):724-34. [EMBASE: 1989253098]2757879
94. Atsushi K, Shotaro H, Yusho M, Akira S, Hachiro T, Shoji O, et al. Evaluation of therapeutic effects of terfenadine on chronic urticaria: double blind comparative study with clemastine [Terfenadine no Mansei Jimmashin ni Taisuru Yuyosei no Kenrto: Clemastine o Taisho to Shita Niju Moken Gunkan Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1985;1(9):1297-310. [CENTRAL: CN-00475854]2757881
95. Bakos L. Comparative trial between terfenadine and dexchlorpheniramine in chronic urticaria [Estudo comparativo do terfenadine versus dextroclorofeniramina em urticaria cronica]. Revista Brasileira de Clinica e Terapeutica 1985;14(1-2):47-9. [EMBASE: 1985124642]2757883
96. Baraf CS. Treatment of pruritus in allergic dermatoses: an evaluation of the relative efficacy of cyproheptadine and hydroxyzine. Current Therapeutic Research Clinical and Experimental 1976;19(1):32-8. [MEDLINE: 812662]2757885
97. Bernd LAG. Astemizol and terfenadine: double-blind study in the treatment of chronic urticaria [Estudo duplo-cego entre astemizol e terfenadina no tratamento da urticaria cronica]. Folha Medica 1989;99(5-6):295-300. [EMBASE: 1990061508]2757887
98. Bernstein IL, Bernstein DI. Efficacy and safety of astemizole, a long-acting and non-sedating H1 antagonist for the treatment of chronic idiopathic urticaria. Journal of Allergy & Clinical Immunology 1986;77(1 Pt 1):37-42. [MEDLINE: 3080510]2757889
99. Bernstein JA, Levin L, Zhong W. Combination treatment with cetirizine and zafirlukast improves urticaria in patients with autoantibody to FcE1 receptors [Abstract 476]. American Academy of Allergy Asthma and Immunology 58th Annual Meeting. New York, New York, USA. March 1-6, 2002. Journal of Allergy, Asthma & Immunology. 2002; Vol. 109 (Suppl 1). 2757891
100. Bian ZP, Qian ML, Mao NE, Luo BG. A randomised controlled trial of loratadine versus astemizole in the treatment of chronic urticaria (Chinese). Journal of Clinical Dermatology 1996;25(3):165-6. 2757893
101. Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CT, Hindley F, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. British Journal of Dermatology 1987;117(1):81-8. [MEDLINE: 3307890]2757895
102. Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children. Current Medical Research & Opinion 2004;20(12):1959-65. [MEDLINE: 15701213]2757897
103. Brunet C, Bedard PM, Hebert J. Effects of H1-antihistamine drug regimen on histamine release by non-lesional skin mast cells of patients with chronic urticaria. Journal of Allergy & Clinical Immunology 1990;86(5):787-93. [MEDLINE: 1699989]2757899
104. Cainelli T, Seidenari S, Valsecchi R, Mosca M. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. Pharmatherapeutica 1986;4(10):679-86. [MEDLINE: 2885854]2757901
105. Camarasa JM, Aliaga A, Fernandez-Vozmediano JM, Fonseca E, Iglesias L, Tagarro I. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trial. Skin Pharmacology & Applied Skin Physiology 2001;14(2):77-86. [MEDLINE: 11316966]2757903
106. Cassano N, Cesare G, Tsapoga V, Vena GA. Cyclosporin in chronic urticaria: state of the art [Ciclosporina nell'orticaria cronica: stato dell'arte]. Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale 2007;61(1):6-11. [EMBASE: 2007300249]2757905
107. Cerio R, Lessof MH. Treatment of chronic idiopathic urticaria with terfenadine. Clinical Allergy 1984; Vol. 14, issue 2:139-41. [MEDLINE: 6423314]2757907
108. Chatterjee G, Banerjee PK. A comparison of the efficacy of cetirizine and terfenadine in chronic idiopathic urticaria. Indian Journal of Dermatology 1996;41(3):82-6. [CENTRAL: CN-00663322]2757909
109. Chen LY, Guo YQ. Observation on short-term therapeutic effect of Bo's abdominal acupuncture on chronic urticaria [Chinese]. Zhongguo Zhenjiu 2005;25(11):768-70. [MEDLINE: Chinese translation OBTAINED]2757911
110. Church D, Baiardini I, Staevska M, Popov T, Kralimarkova T, Dimitrov V, et al. The effectiveness of antihistamines in up to four-times conventional doses on urticarial discomfort and quality of life in difficult-to-treat urticaria [Abstract]. 28th Congress of the European Academy of Allergy and Clinical Immunology Abstract Book Warszawa Poland. Conference Start: 20090606 Conference End: 20090610. Allergy: European Journal of Allergy & Clinical Immunology 2009;64:571. [EMBASE: 70021424]2757913
111. Cook LJ, Shuster S. Lack of effect of cimetidine in chronic-idiopathic urticaria. Acta Dermato-Venereologica 1983;63(3):265-7. [MEDLINE: 6192652]2757915
112. Demaubeuge J, Tennstedt D, Broux R. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. Dermatologica 1982; Vol. 164, issue 6:386-94. [MEDLINE: 6126399]2757917
113. Devillier P, Bousquet J. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?. Clinical & Experimental Allergy 2007;37(3):400-14. [MEDLINE: 17359390]2757919
114. Devillier P, Roche N, Faisy C. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review. Clinical Pharmacokinetics 2008;47(4):217-30. [MEDLINE: 18336052]2757921
115. Dhurandhar MW, Sharma SD. Azatadine versus pheniramine in chronic urticaria. Medicine and Surgery 1987;27(9):15-7. [EMBASE: 1988189679]2757923
116. Diller G, Orfanos CE. Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study [Behandlung der idiopathischen urticaria mit H1+H2 antagonisten. Ergebnisse einer crossover-doppelblind-langzeitstudie]. H+G Zeitschrift für Hautkrankheiten 1983;58(11):785-93. [EMBASE: 1983171814]2757925
117. Dockx P, Vertommen J, Van Daele R. Oxatomide effective in chronic urticaria: a double-blind comparison with a placebo. Current Therapeutic Research Clinical and Experimental 1981;29(3 II):510-6. [EMBASE: 1981227927]2757927
118. Farshchain M. Comparison of ketotifen effectiveness with hydroxyzine in the treatment of pruritus and chronic idiopathic urticaria [Abstract]. 20th World Congress of Dermatology Paris, 1st to 5th July 2002. Annales de Dermatologie et de Venereologie 2002;129:P1667. 2757929
119. Ferguson J, MacDonald KJ, Kenicer KJ. Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study. British Journal of Clinical Pharmacology 1985;20(6):639-41. [MEDLINE: 3937549]2757931
120. Fox RW, Lockey RF, Bukantz SC, Serbousek D. The treatment of mild to severe chronic idiopathic urticaria with astemizole: double-blind and open trials. Journal of Allergy & Clinical Immunology 1986;78(6):1159-66. [MEDLINE: 3097109]2757933
121. Fredriksson T, Hersle K, Hjorth N, Mobacken H, Persson T, Salde L, et al. Terfenadine in chronic urticaria: a comparison with clemastine and placebo. Cutis 1986; Vol. 38, issue 2:128-30. [MEDLINE: 2874958]2757935
122. Gao H, Li XZ, Ye WW, Zhou BY, Jin YJ, Qiu Y, et al. [Influence of penetrative needling of Shendao (GV 11) on the symptom score and serum IgE content in chronic urticaria patients]. Zhen Ci Yan Jiu = Acupuncture Research/[Zhongguo Yi Xue Ke Xue Yuan Yi Xue Qing Bao Yan Jiu Suo Bian Ji] 2009; Vol. 34, issue 4:272-5. [MEDLINE: CHINESE TRANSLATION OBTAINED]2757937
123. Ge ZP, Luo CH. The efficacy contrast between doxepin and cyproheptadine for chronic urticaria (Chinese). Journal of Clinical Dermatology 1987;16(5):242-3. 2757939
124. Giannetti A, Motolese A. Controlled clinical study of cetirizine versus astemizole in patients with idiopathic chronic urticaria [Studio clinico controllato ceririzina verso astemizolo in pazienti con orticaria cronica idiopatica]. Chronica Dermatologica 1991;1(3):321-35. [EMBASE: 1991245329]2757941
125. Gibson JR, Harvey SG, Barth JH, Moss MY, Burke CA. An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study. Dermatologica 1984; Vol. 169, issue 4:179-83. [MEDLINE: 6149965]2757943
126. Godse KV. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian Journal of Dermatology, Venereology & Leprology 2006;72(4):312-4. [MEDLINE: 16880585]2757945
127. Gong J, Gao GB, Zhang W. Combined treatment with cetirizine, cimetidine and dipyridamole in 57 patients with chronic urticaria (Chinese). Journal of Clinical Dermatology 1995;24(3):163-4. 2757947
128. Gonzalez-Morales JE, Leal De Hernandez L, Welsh O. Tolerance and efficacy of terfenadine compared with placebo in idiopathic chronic urticaria [Tolerancia y eficacia de la tefernadina contra placebo en el tratamiento de la urticaria cronica idiopatica. Estudio comparativo doble ciego.]. Dermatologia Revista Mexicana 1985;29(3):100-4. [EMBASE: 1987098302]2757949
129. Greaves MW. Antihistamine treatment: a patient self-assessment method in chronic urticaria. British Medical Journal (Clinical Research Edition) 1981;283(6304):1435-6. [MEDLINE: 6119130]2757951
130. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. Journal of the American Academy of Dermatology 1985;12(4):669-75. [MEDLINE: 3886724]2757953
131. Grob JJ, Auquier P, Dreyfus I, Ortonne JP. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy 2009;64(4):605-12. [PUBMED: 19133920]2757955
132. Guaglianone MH, Vergallo G, Iudice A, Henauer S. Once a day dosage of terfenadine in chronic urticaria: a double-blind comparison with the standard dosage. Arerugi [Allergy] 1988;43(Suppl 7):94. 2757957
133. Guerra L, Vincenzi C, Marchesi E, Tosti A, Pretto E, Bassi R, et al. Loratadine and cetirizine in the treatment of chronic urticaria. Journal of the European Academy of Dermatology & Venereology 1994;3(2):148-52. [EMBASE: 1994126862]2757959
134. Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006;66(7):973-96. [MEDLINE: 16740020]2757961
135. Hamerlinck FFV, Boyden B, Oei HD, Niordson AM, Avrach W, Ottevanger V, et al. A double-blind comparative study of loratadine and astemizole in chronic idiopathic urticaria. Journal of Dermatological Treatment 1994;5(4):199-202. [EMBASE: 1995029316]2757963
136. Hampel F, Nayak A, Texter M. The safety and tolerability of levocetirizine dihydrochloride in children 1-5 years with allergic rhinitis or chronic idiopathic urticaria. Conference: Southwest Allergy Forum Puerto Vallarta Mexico. Conference Start: 20090114 Conference End: 20090118. Allergy & Asthma Proceedings 2009;30(2):209. [EMBASE: 70148899]2757965
137. Hampel F, Ratner P, Haeusler JMC. Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria. Allergy & Asthma Proceedings 2010;31(4):290-5. [EMBASE: 2010482204]2757966
138. NCT00619801. A multi-center, randomized, double blind, placebo controlled parallel group study of the safety of levocetirizine dihydrochloride oral liquid formulation b.i.d dosing in children aged 1 to < 6 years suffering from allergic rhinitis or chronic urticaria of unknown origin [completed]. clinicaltrials.gov/show/NCT00619801 (accessed 31 Jul 2008). 2757967
139. Han G, Ran LH. The curative effect observation of terfenadine for 116 cases hives (Chinese). Journal of Clinical Dermatology 1992;21(3):159. 2757969
140. Hong JB, Lee HC, Hu FC, Chu CY. A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria. Journal of the American Academy of Dermatology 2010; Vol. 63, issue 5:e100-2. [MEDLINE: 20950731]2757971
141. Honsinger RW Jr, Thomsen RJ. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole. Annals of Allergy 1990;65(3):194-200. [MEDLINE: 1976298]2757973
142. Huo HM. Efficacy observation on acupuncture combined with bloodletting for chronic urticaria. Zhongguo Zhenjiu = Chinese Acupuncture & Moxibustion 2014; Vol. 34, issue 1:41-3. [MEDLINE: 24673054]2757975
143. Ishibashi Y, Yoshida H, Kukita A, Harada S, Nishikawa T, Okawara A, et al. Dose finding study of astemizole (MJD-30) on chronic urticaria [Astemizole (MJD-30) no Mansei Jimmashin ni Okeru Shiteki Yoryo no Kento]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1989;5(12):2531-43. [CENTRAL: CN-00547587]2757977
144. Ishibashi Y, Harada S, Niimura M, Ueda H, Imamura S, Yamamoto S, et al. Clinical evaluation of KG-2413 (emedastine difumarate) on chronic urticaria by multicenter double-blind study: comparative study between 2mg/day, 4mg/day, and ketotifen fumarate [Tashisetsu Niju Mokenho ni Yoru Mansei Jimmashin ni Taisuru Ko Arerugi Zai KG-2413 (Fumarusan Emedasuchin) no Rinsho Hyoka: 2mg/Nichi, 4mg/Nichi Oyobi Fumarusan Ketoshifen ni Yoru 3 Gunkan Hikaku Seiseki]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1990;6(1):141-59. [CENTRAL: CN-00547345]2757979
145. Ishibashi Y, Harada S, Kukita A, Nishikawa T, Yoshida H, Okawara A, et al. A clinical study of astemizole (MJD-30) in treating chronic urticaria: a double blind, comparative study using ketotifen fumarate as a control drug [Astemizole (MJD-30) no Mansei Jimmashin ni Taisuru Rinsho Shiken: Ketotifen Fumarate o Taishoyaku to Shita Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1990;6(8):1623-38. [CENTRAL: CN-00547150]2757981
146. Ishibashi Y, Harada S, Kukita A, Nishikawa T, Yoshida H, Okawara A, et al. A clinical study of astemizole (MJD-30) in treating chronic urticaria: a double blind, comparative study using ketotifen fumarate as a control drug [Astemizole (MJD-30) no Mansei Jimmashin ni Taisuru Rinsho Shiken: Ketotifen Fumarate o Taishoyaku to Shita Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1990;6(8):1623-38. [CENTRAL: CN-00547150]2757983
147. Ishibashi Y, Harada S, Niimura M, Kawashima M, Yamamoto S, Yoshida H, et al. A multicenter double-blind comparative study: clinical evaluation of TAU-284 (betotastine besilate) on chronic urticaria using terfenadine as a control drug [TAU-284 (Beshirusan Betotasuchin) no Mansei Jimmashin ni Taisuru Rinsho Hyoka: Terufenajin o Taishoyaku to Shita Tashisetsu Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1997;13(5):1287-306. [CENTRAL: CN-00547332]2757985
148. Ishibashi, Y, Harada, S, Niimura, M. Early phase II study of TAU-284 (betotastine besilate) on chronic urticaria [in Japanese]. Rinsho Iyaku 1997;13(5):1199-215. 2757987
149. Ishibashi, Y, Harada, S, Niimura, M. Late phase II study of TAU-284 (betotastine besilate) on chronic urticaria: optimal dose finding study by double-blind technique [in Japanese]. Rinsho Iyaku 1997; Vol. 13, issue 5:1237-57. 2757989
150. Isola E, Rosengarten S, Torre F. Comparative multicenter study of the tolerance and efficacy of terfenadine vs placebo in chronic urticaria [Estudio multicentrico comparativo sobre tolerancia y eficacia de terfenadina vs. placebo en urticaria cronica]. Investigación Médica Internacional 1985;12(1):40-8. [EMBASE: 1985205432]2757991
151. Jauregui I, Mullol J, Bartra J, del Cuvillo A, Davila I, Montoro J, et al. H1antihistamines: psychomotor performance and driving. Journal of Investigational Allergology & Clinical Immunology 2006;16(Suppl 1):37-44. [MEDLINE: 17357376]2757993
152. Jia H, Liu XQ, Li HZ, Lin L, Cao YH, Cui PG, et al. Clinical observation on the efficacy of domestic cetirizine in the treatment of urticaria (Chinese). Chinese Journal of Dermatology 1998;31(5):339. 2757995
153. Jolliffe DS, Sim-Davis D, Templeton JS. A placebo-controlled comparative study of sustained-release brompheniramine maleate against clemastine fumarate in the treatment of chronic urticaria. Current Medical Research & Opinion 1985;9(6):394-9. [MEDLINE: 3886304]2757997
154. Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride, a non-sedating antihistamine. British Journal of Dermatology 1988;119(1):67-71. [MEDLINE: 2900648]2757999
155. Jyothi CH, Kiran LJ, Shashikala GH, Ravindra K, Santhosh R. Comparative study on safety and efficacy of loratadine, prednisolone & their combination in the treatment of chronic urticaria. Pharmacologyonline 2011;3:988-96. [EMBASE: 2012087113]2758001
156. Kailasam V, Mathews KP. Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema. Journal of the American Academy of Dermatology 1987; Vol. 16, issue 4:797-804. [MEDLINE: 2883202]2758003
157. Kalimo K, Jansen CT. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine). Annals of Allergy 1980;44(1):34-7. [MEDLINE: 7352689]2758005
158. Kalis B, Morel P, Prigent F. Chronic and cholinergic urticarias. Double blind comparison of mequitazine and hydroxyzine [Urticaires chroniques et cholinergiques. Etude comparative en double aveugle de la mequitazine et de l'hydroxyzine]. Medecine et Hygiene 1985;43(1604):1133-6. [EMBASE: 1985098611]2758007
159. Kalis B. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drugs 1996;52(Suppl 1):30-4. [MEDLINE: 8828024]2758009
160. Kameyoshi Y, Tanaka T, Mihara S, Takahagi S, Niimi N, Hide M. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. British Journal of Dermatology 2007;157(4):803-4. [MEDLINE: 17627798]2758011
161. Kamide R, Niimura M, Ueda H, Imamura S, Yamamoto S, Yoshida H, et al. Clinical evaluation of ketotifen for chronic urticaria: multicenter double-blind comparative study with clemastine. Annals of Allergy 1989;62(4):322-5. [MEDLINE: 2650586]2758013
162. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. Journal of Allergy & Clinical Immunology 2008;122(3):569-73. [MEDLINE: 18774392]2758015
163. Kapp A, Wedi B. Chronic urticaria: clinical aspects and focus on a new anti-histamine, levocetirizine. Journal of Drugs in Dermatology 2004;3(6):502-8. 2758017
164. Kapp A, Demarteau N. Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials. Clinical Drug Investigation 2006; Vol. 26, issue 1:1-11. [MEDLINE: 17163229]2758019
165. Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. International Journal of Dermatology 2006; Vol. 45, issue 4:469-74. [MEDLINE: 16650180]2758021
166. Kawada A, Furukawa F, Hide M. Comparative efficacy of continuous and intermittent use of epinastine for chronic urticaria in an 8-week randomized, multicenter, parallel-group study [Abstract]. 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204. Journal of the American Academy of Dermatology 2011;64(2 Suppl 1):AB32. [EMBASE: 70331444]2758023
167. Kawashima M, Harada S, Nakashima M. Phase III study of TAU-284 (bepotastine besilate) on chronic urticaria, a multicenter double blind comparative study with placebo. Rinsho Iyaku 2002;18:501-18. 2758025
168. Khalaf AT, Liu XM, Sheng WX, Tan JQ, Abdalla AN. Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria. Journal of the European Academy of Dermatology & Venereology 2008;22(4):487-92. [MEDLINE: 18081747]2758027
169. Kietzmann H, Macher E, Rihoux JP, Ghys L. Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Annals of Allergy 1990;65(6):498-500. [MEDLINE: 1979471]2758029
170. Kim S, Baek S, Shin B, Yoon S-Y, Park SY, Lee T, et al. Influence of initial treatment modality on long-term control of chronic idiopathic urticaria. Plos ONE. 7. Public Library of Science. US, 2013; Vol. 8, issue 7:e69345. 2758031
171. Kukita A, Harada S, Miura Y, Ishihara M, Takahashi H, Nonami E, et al. Investigation on the optimal dose of terfenadine: result by double blind study, double dummy method, for chronic urticaria [Terfenadine no Shiteki Toyoryo no Kento: Mansei Jimmashin o Taisho to Shita Niju Moken Genkan Hikaku Shiken Seiseki]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1985;1(9):1283-95. [CENTRAL: CN-00475853]2758033
172. Kukita A, Harada S, Miura Y, Shirato A, Tagami H, Okamoto S, et al. Evaluation of therapeutic effects of terfenadine on chronic urticaria: double blind comparative study with clemastine [Terfenadine no Mansei Jimmashin ni Taisuru Yuyosei no Kenrto: Clemastine o Taisho to Shita Niju Moken Gunkan Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1985;1(9):1297-310. [CENTRAL: CN-00475854]2758035
173. Kukita A, Harada S, Okawara A, Takahashi M, Tagami H, Ishibashi Y, et al. Clinical usefulness of loratadine on chronic urticaria: multicenter double blind study in comparison with mequitazine [Loratadine no Mansei Jimmashin ni Taisuru Yuyosei no Kento: Mequitazine o Taishoyaku to Shita Tashisetsu Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1990;6(12):2689-705. [CENTRAL: CN-00542666]2758037
174. Kukita A, Harada S, Okawara A, Takahashi M, Tagami H, Ishibashi Y, et al. Dose-finding clinical trial of loratadine on chronic urticaria: double blind controlled study [Loratadine no Shiteki Toyoryo Oyobi Toyo Hoho no Kento: Mansei Jimmashin o Taisho to Shita Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1990;6(10):2037-50. [CENTRAL: CN-00542675]2758039
175. Kukita A, Harada S, Okawara A, Takahashi M, Tagami H, Ishikawa H, et al. Phase III study of WAL801CL (Epinastine) on chronic urticaria: a double blind study in comparison with ketotifen fumarate [WAL801CL (Epinastine) Jo no Mansei Jimmashin ni Taisuru Rinsho Dai III So Shiken: Ketotifen Fumarate o Taishoyaku to Shita Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1991;7(10):2303-20. [CENTRAL: CN-00542689]2758041
176. Kukita A, Harada S, Yoshida H, Ishibashi Y, Niimura M, Yamamoto S, et al. Phase III study of LAS-90 on chronic urticaria: double blind comparative study with ketotifen fumarate [LAS-90 no Mansei Jimmashin ni Taisuru Rinsho Dai III So Shiken: Ketotifen Fumarate o Taishoyaku to Shita Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1994;10(4):895-912. [CENTRAL: CN-00542704]2758043
177. Kukita A, Harada S, Yoshida H, Ishibashi Y, Niimura M, Yamamoto S, et al. Late phase II study of LAS-90 on chronic urticaria: optimal dose finding study by double-blind technique [LAS-90 no Mansei Jimmashin ni Taisuru Koki Rinsho Dai II So Shiken: Niju Mokenho ni Yoru Yoryo Settei Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1994;10:55-72. [CENTRAL: CN-00542708]2758045
178. Kuokkanen K, Paavilainen O. Evaluation of slow-releasing diphenylpyraline in chronic urticaria and various kinds of dermatites. Acta Allergologica 1971;26(6):454-62. [MEDLINE: 4401352]2758047
179. Kuokkanen K. A new antihistamine hc20-511 compared with dimetinden (fenistil retard) in the treatment of chronic urticaria and other pruritic dermatoses. Acta Allergologica 1975;30(2-3):73-9. [MEDLINE: 239517]2758049
180. Kuokkanen K. Comparison of a new antihistamine HC 20-511 with cyproheptadine (Periactin) in chronic urticaria. Acta Allergologica 1977;32(5):316-20. [MEDLINE: 21504]2758051
181. Lambert D, Bloom M, Danglas P. Comparative double blind study of the delay of activity, efficacy and tolerance of terfenadine versus astemizole in the treatment of idiopathic chronic urticaria [Etude comparative en double aveugle du delai d'action, de l'efficacite et de la tolerance de la terfenadine versus astemizole dans l'urticaire chronique idiopathique]. Comptes Rendus de Therapeutique et de Pharmacologie Clinique 1990;8(88):21-7. [EMBASE: 1991294093]2758053
182. Lambert D, Hantzperg M, Danglas P, Bloom M. Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria [Etude comparative en double-aveugle de la terfenadine et de la cetirizine dans l'urticaire chronique idiopathique]. Allergie et Immunologie 1993; Vol. 25, issue 6:235-40. [MEDLINE: 8357472]2758055
183. Lambert D, Hantzperg M, Danglas P, Bloom M. Chronic idiopathic urticaria: multicentre, double-blind comparison of terfenadine and cetirizine [Etude comparative en double-aveugle de la terfenadine et de la cetirizine dans l'urticaire chronique idiopathique]. Allergie et Immunologie 1993;25(6):235-236, 238-240. [EMBASE: 1993223997]2758057
184. Lan CG, Li H, Lin YK, Wu JJ, Wang XL, Ni ZZ. Efficacy and safety of desloratadine in the treatment of acute and chronic idiopathic urticaria. Chinese Journal of New Drugs 2002;11(8):631-3. 2758059
185. La Rosa M, Leonardi S, Marchese G, Corrias A, Barberio G, Oggiano N, et al. Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. Annals of Allergy, Asthma, & Immunology 2001;87(1):48-53. [MEDLINE: 11476462]2758061
186. Lennox RD, Leahy MJ. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Annals of Allergy, Asthma, & Immunology 2004; Vol. 93, issue 2:142-6. [MEDLINE: 15328673]2758063
187. Li H, Yin J, Wen L, Yue F, Fang Q, Wang R, et al. Mizolastine provides effective symptom relief in patients suffering from chronic idiopathic urticaria: a randomized comparative study versus loratadine in China [Abstract]. American Academy of Allergy Asthma and Immunology, San Francisco, California, March 19-23 2004. Journal of Allergy & Clinical Immunology 2004;113(2 Suppl):S136. [CENTRAL: CN-00475902]2758065
188. Liu LL, Zhu XJ. A study on the efficacy and safety of astemizole versus loratadine in the treatment of chronic idiopathic urticaria. Chinese Journal of Dermatovenereology 2002;16(1):14-6. [CENTRAL: CN-00401668]2758067
189. Magerl M, Schmolke J, Metz M, Zuberbier T, Siebenhaar F, Maurer M. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clinical & Experimental Dermatology 2009;34(5):e137-40. [MEDLINE: 19323664]2758069
190. Magerl M, Rother M, Bieber T, Biedermann T, Brasch J, Dominicus R, et al. Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria. Journal of the European Academy of Dermatology & Venereology 2013;27(3):e363-9. [EMBASE: 2013118378]2758071
191. Maurer M, Rosen K, Hsieh HJ, Saini S, Grattan C, Gimenez-Arnau A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. New England Journal of Medicine 2013;368(10):924-35. [MEDLINE: 23432142]2758073
192. Meloy LD, Ratner PH, Texter MJ. The safety and tolerability of levocetirizine dihydrochloride in infants 6-11 months with allergic rhinitis or chronic idiopathic urticaria [Abstract]. Western Society of Allergy, Asthma, and Immunology Meeting Wailea, HI United States. Conference Start: 20090125 Conference End: 20090129. Allergy & Asthma Proceedings 2009;30(2):210. [EMBASE: 70148903]2758075
193. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Archives of Dermatology 1981;117(7):404-7. [MEDLINE: 6114712]2758077
194. Monroe EW, Gross G, Meeves S, Liao Y, Varghese ST, Georges G. Once-daily fexofenadine HCl 180 mg is effective for the treatment of CIU [Abstract]. American Academy of Allergy, Asthma and Immunology (AAAAI) 61st annual meeting. San Antonio, Texas, USA, March 18-22, 2005. Journal of Allergy & Clinical Immunology 2005;115(2 Suppl):S106. [CENTRAL: CN-00518315]2758079
195. Monteseirin Mateo J, Bobadilla Gonzalez P, Galindo Bonilla PA, Conde Hernandez J. Cinnarizine: a double-blind study in patients with chronic urticaria [Estudio a doble ciego con cinarizina de pacientes con urticaria crónica]. Revista Española de Alergología e Inmunología Clínica 1992;7(2):71-4. [EMBASE: 1992171673]2758081
196. Mora PM, Gonzalez Perez Mdel C, Jimenez Villarruel M, Rodriguez Castro E, Fogelbach GG. Therapeutic options in idiopathic chronic urticaria [Opciones terapeuticas en urticaria cronica idiopatica]. Revista Alergia México 2005;52(2):77-82. [MEDLINE: 16158780]2758083
197. Nakayama Y, Akasaka T, Baba M, Iwasaki E, Funahashi S, Nishimuta T, et al. A double blind controlled trial of azatadine maleate syrup (idulamine syrup) in children with urticaria or atopic dermatitis. Comparison of effectiveness and side effect with d chlorpheniramine maleate syrup. Rinsho Hyoka: Clinical Evaluation 1980;8(1):235-78. [CENTRAL: CN-00268192]2758085
198. Neumann Y. Antihistaminic therapy of chronic urticaria. Results of a multicenter study with azatadine and terfenadine [Antihistaminika-Behandlung bei chronischer Urtikaria. Ergebnisse einer Multicenter-Studie mit Azatadin und Terfenadin]. Fortschritte der Medizin 1984;102(38):967-70. [MEDLINE: 6209194]2758087
199. Nishiyama S, Okamoto S, Ishibashi Y, Nishikawa T, Nishioka K, Nagai T. Phase III Study of KW-4679 (Olopatadine Hydrochloride) on Chronic Urticaria: A Double Blind Study in Comparison with Ketotifen Fumarate [KW-4679 (Ensan Oropatajin) Jo no Mansei Jimmashin ni Taisuru Dai III So Hikaku Shiken: Fumarusan Ketochifen o Taishoyaku to Shita Niju Moken Hikaku Shiken]. Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines) 1996;12(9):1855-82. [CENTRAL: CN-00542941]2758089
200. Nsouli SM. Efficacy of omalizumab, an anti-IgE recombinant humanized, monoclonal antibody, for the treatment of severe chronic idiopathic urticaria patients not controlled on oral antihistamines. Conference: 2013 Annual Meeting of the American College of Allergy, Asthma and Immunology Baltimore, MD United States. Conference Start: 20131107 Conference End: 2013. Annals of Allergy, Asthma & Immunology 2013;111(5 Suppl 1):A117. [EMBASE: 71307206]2758091
201. Ormerod AD, Baker R, Watt J, White MI. Terfenadine and brompheniramine maleate in urticaria and dermographism. Dermatologica 1986;173(1):5-8. [MEDLINE: 2875904]2758093
202. Ortonne J. Fexofenadine hydrochloride: a new anti-H1 in the treatment of chronic idiopathic urticaria. Study comparing the efficacy and safety of four dosage regimes [Abstract ST7-5]. The 7th Congress of the European Academy of Dermatology and Venereology, Nice, 7-11 Ocober 1998. Journal of the European Academy of Dermatology & Venereology 1998;11(Suppl 2):S103. 2758095
203. Paul E, Bödecker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study [Therapie der chronischen Urticaria mit Terfenadin und Ranitidin. Eine randomisierte Doppelblind-Studie]. Allergologie 1984;7(4):159. [CENTRAL: CN-00252061]2758097
204. Paul E, Bodeker RH. Comparison between astemizole and terfenadine in the treatment of chronic urticaria: a randomised double blind study of 40 patients. Zeitschrift fur Hautkrankheiten 1985;60(Suppl 1):50-5. [MEDLINE: 2859714]2758099
205. Paul E, Reinel D, Ulrich R, Köhler ME. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria. Arerugi [Allergy] 1988;43(Suppl 7):94. [CENTRAL: CN-00267227]2758101
206. Paul E. Loratadine and terfenadine in the treatment of chronic urticaria. Results of a multicentre study. Arerugi [Allergy] 1988;43(Suppl 7):122. [CENTRAL: CN-00267241]2758103
207. Paul E. Loratadine and terfenadine in the treatment of chronic urticaria. Arerugi [Allergy] 1988;43(Suppl 7):92. [CENTRAL: CN-00267223]2758105
208. Paul E, Reinel D, Ulrich R, Kohler ME. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria. Annals of Allergy 1989;63(4):340-2. [MEDLINE: 2572189]2758107
209. Paul E, Bodeker RH. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients. Annals of Allergy 1989;62(4):318-20. [MEDLINE: 2565098]2758109
210. Paul E. Comparsion of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Results of an international multi-centre-study [Vergleich von Loratadin und Terfenadin in der Behandlung der chronischen idiopathischen Urticaria. Ergebnisse einer International Multi-Center-Studie]. Allergologie 1989;11(5):198. [CENTRAL: CN-00661504]2758111
211. Pavic I, Hojsak I, Cepin-Bogovic J. Evidence-based management of chronic urticaria in children. Pediatric, Allergy, Immunology, & Pulmonology 2012;25(4):198-207. [EMBASE: 2012732053]2758113
212. Peremans W, Mertens RL, Morias J, Campaert H. Oxatomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial. Dermatologica 1981; Vol. 162, issue 1:42-50. [MEDLINE: 7014277]2758115
213. Presch A, Gorlich HD, Paul E. Terfenadine 120 mg vs. cetirizine 10 mg in patients with chronic idiopathic urticaria [Vergleich zwischen terfenadin 120 mg und cetirizin 10 mg bei chronischer idiopathischer urtikaria. Eine kontrollierte randomisierte doppelblinde multizentrische studie]. Allergo Journal 1996;5(1):31-5. [EMBASE: 1996071782]2758117
214. Saihan EM, Littlewood SN. Ketotifen and terbutaline in chronic urticaria [Abstract]. British Journal of Dermatology 1983;109(Suppl 24):31. [EMBASE: 1983200922]2758119
215. Salisbury J, Bor S, Blair C. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria. British Journal of Clinical Practice 1987;41(8):859-61. [MEDLINE: 2896512]2758121
216. Salmun LM, Herron JM, Banfield C, Padhi D, Lorber R, Affrime MB. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clinical Therapeutics 2000;22(5):613-21. [MEDLINE: 10868558]2758123
217. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Aspirin-exacerbated cutaneous disease. Immunology & Allergy Clinics of North America 2013;33(2):251-62. [MEDLINE: 23639712]2758125
218. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?. Journal of Investigational Allergology & Clinical Immunology 2013;23(3):141-4. [MEDLINE: 23967751]2758127
219. Shah BH, Sharma SD. Comparative clinical study of azatadine and pheniramine in chronic urticaria. Current Therapeutic Research Clinical and Experimental 1986;39(3):383-7. [EMBASE: 1987093636]2758129
220. Shareeah A, Youssuf M, Deckers I, De MC. Double-blind, parallel, randomized pilot study comparing the efficacy and tolerance of cetirizine 10 mg, mequitazine 2 x 5 mg and placebo in the treatment of patients suffering from chronic urticaria: comparison of suppressive effects on histamine-induced weals and flares. Drug Development Research 1998;43(4):185-92. 2758131
221. Shereff PH, Shah JK, Rawal RC, Shah BH. Comparative study of various therapeutic regimens in chronic urticaria. Indian Journal of Dermatology, Venerology & Leprology 1984;50(2):45-7. [CENTRAL: CN-00692723]2758133
222. Sim-Davis D, Templeton JS. A placebo-controlled comparative study of Dimotane LA against Optimine in the treatment of chronic urticaria with or without dermographism. British Journal of Clinical Practice 1983;37(7-8):253-8. [MEDLINE: 6136296]2758135
223. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria [Abstract no:1]. Indian Journal of Dermatology, Venerology & Leprology 1995;61:250. [CENTRAL: CN-00692606]2758137
224. Singh M, Kaur S. Relative efficacy of seven common H1 receptor antagonist antihistamines in chronic idiopathic urticaria. Indian Journal of Dermatology, Venereology & Leprology 1987;53(3):158-61. [EMBASE: 1988089884]2758139
225. Sobye P, Ulrich J. Dimethpyrindene and a new antihistamine HS 592 (Sandoz) in the treatment of severe chronic urticaria. Acta Allergologica 1968;23(1):24-34. [MEDLINE: 4385407]2758141
226. Staevska M, Popov T, Kralimarkova T, Lazarova C, Kraeva S, Popova D, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult to treat urticaria. Journal of Allergy & Clinical Immunology 2010;125(3):676-82. [MEDLINE: 20226302]2758143
227. Staevska, M, Kralimarkova T, Kraeva S, Lazarova C, Church, M, Dimitrov V, Popov T. Determinants of the success of treatment of subjects with chronic urticaria on higher than conventional doses of levocetirizine and desloratadine. Poster presentation. 2008. 2758144
228. Sussman G, Jancelewicz Z. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria. Annals of Allergy 1991;67(4):433-9. [MEDLINE: 1683191]2758146
229. Taskapan O, Sener O, Ozangue N. Cetirizine versus ketotifen in chronic idiopathic urticaria CIU: a single-blind, placebo-controlled study. Annals of Allergy, Asthma & Immunology 2000;84:138. [CENTRAL: CN-00385423]2758148
230. Tilles SA. Approach to therapy in chronic urticaria: when benadryl is not enough. Allergy & Asthma Proceedings 2005;26(1):9-12. [MEDLINE: 15813282]2758150
231. Valsecchi R, Tribbia G, Frigeni A. Oxatomide in treatment of chronic urticaria [IMPIEGO DELL'OXATOMIDE NELLA TERAPIA DELL'ORTICARIA CRONICA]. Annali Italiani di Dermatologia Clinica e Sperimentale 1984;38(3):323-8. [EMBASE: 1985054439]2758152
232. Van Cauwenberge P, De Belder T, Sys L. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders. Expert Opinion on Pharmacotherapy 2004;5(8):1807-13. [MEDLINE: 15264995]2758154
233. van Joost T, Blog FB, Westerhof W, Jansen FC, Starink TM, den Boer MS, et al. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. Journal of International Medical Research 1989;17(Suppl 2):14B-7B. [MEDLINE: 2569995]2758156
234. Vena GA, Cassano N, Filieri M, Filotico R, D'Argento V, Coviello C. Fexofenadine in chronic idiopathic urticaria: a clinical and immunohistochemical evaluation. International Journal of Immunopathology & Pharmacology 2002; Vol. 15, issue 3:217-24. [EMBASE: 2002402529]2758158
235. Verhaegen H, De Cree J. Oxatomide in the treatment of idiopathic chronic urticaria. A placebo-controlled study [Behandlung der Chronisch-Idiopathischen Urtikaria mit Oxatomid. Ein Plazebo-Kontrollierter Versuch]. Allergologie 1980; Vol. 3, issue 1:30-3. [EMBASE: 1980131639]2758160
236. Vijay M, Rawal RC, Billimoria FE. A comparative study of efficacy of cetirizine versus astemizole in chronic idiopathic urticaria. Indian Journal of Dermatology, Venerology & Leprology 1994;60(4):203-5. [EMBASE: 1995045872]2758162
237. Wang BZ, Wang X. A randomised controlled trial of cetirizine versus chlorpheniramine maleate in the treatment of urticaria of children (Chinese). Journal of Clinical Dermatology 1998;27(3):174-5. 2758164
238. Wang KY, Li CY, Yu YJ, Sun XX, Gao HR. Cetirizine in treating chronic urticaria in 113 patients. Chinese Journal of New Drugs & Clinical Remedies 2000;19(1):19-20. 2758166
239. Warin RP, Moore-Robinson M. A clinical trial of brompheniramine maleate in chronic urticaria. Practitioner 1966;197(178):212-4. [MEDLINE: 4380315]2758168
240. Watson NT, Weiss EL, Harter PM. Famotidine in the treatment of acute urticaria. Clinical & Experimental Dermatology 2000; Vol. 25, issue 3:186-9. [MEDLINE: 10844490]2758170
241. Weitgasser H. Ambulatory testing of a new antihistaminic. Experience with Tavegil [Ambulante Prufung eines neuen Antihistaminikums. Erfahrungen mit Tavegil]. Münchener Medizinische Wochenschrift 1967;109(20):1134-6. [MEDLINE: 4384702]2758172
242. Weller K, Ardelean E, Martus P, Zuberbier T, Maurer M. Improved reduction of symptoms by 20 versus 5 mg desloratadine in patients with chronic spontaneous urticaria: first results of a randomised, double-blind trial [Abstract]. 29th Congress of the European Academy of Allergy and Clinical Immunology, EAACI London United Kingdom. Conference Start: 20100605 Conference End: 20100609. Allergy: European Journal of Allergy & Clinical Immunology 2010;65:205-6. [EMBASE: 70177849]2758174
243. Witte F. Chronic urticaria: levocetirizine improves symptoms and quality of life [Chronische urtikaria: levocetirizin bessert symptome und lebensqualitat]. Aktuelle Dermatologie 2006;32(11):454. [EMBASE: 2006599161]2758176
244. Wolfram S. Clinical experience with a new antihistaminic [Klinische Erfahrungen mit einem neuen Antihistaminikum]. Wiener Medizinische Wochenschrift 1967;117(38):868-70. [MEDLINE: 4385553]2758178
245. Wozel G, Sahre EM, Barth J. Effectiveness of combination treatment with H1-(Tavegyl) and H2-antagonists (Altramet) in chronic/chronically-recurrent urticaria [Effektivitat der Kombinationsbehandlung von H1-(Tavegyl) und H2-Antagonisten (Altramet) bei chronischer/chronisch rezidivierender Urtikaria]. Dermatologische Monatschrift 1990;176(11):653-9. [MEDLINE: 2083605]2758180
246. Wu GX, Yang DQ. Ranitidine and cyproheptadine use together for 52 chronic hives (Chinese). Chinese Journal of Dermatovenereology 1992;6(3):166-7. 2758182
247. Yamada M, Ogino S, Horio T, Ikeda T. Effect of a new antihistamine 8599RP on chronic urticaria, with special reference to its comparison with d-chlorpheniramine maleate. Acta Dermatologica-Kyoto English Edition 1968;63(1):107-11. [MEDLINE: 4878092]2758184
248. Youngchaiyud U. Comparison of the efficacy of four antihistamines in chronic urticaria. Journal of the Medical Association of Thailand 1988;71(10):548-52. [MEDLINE: 2907911]2758186
249. Zabel M, Lindscheid KR. Treatment of chronic recidivating urticaria with H1-antagonist oxatomide and terfenadine [Die Behandlung der Chronisch-Rezidivierenden Urtikaria mit den H1-Antagonisten Oxatomid und Terfenadin. Ergebnisse einer Doppelblindstudie]. Therapiewoche 1984;34(30):4454-8. [EMBASE: 1984169236]2758188
250. Zhang CS, Shi XH, Zhang JZ. The efficacy observation of astemizole for 38 cases of chronic hives (Chinese). Journal of Clinical Dermatology 1990;19(1):38. 2758190
251. Zhang HY, Zhang R, Ye ST. Multicenter, double-blind trial of terfenadine in treatment of urticaria and allergic rhinitis in 384 patients. Chinese Journal of New Drugs & Clinical Remedies 1991;10(3):023. [CENTRAL: CN-00715298]2758192
252. Zhang HY, Li H, Yue FM, Wang LL. A multicenter, randomized, comparative study on the safety and efficacy of mizolastine versus loratadine for the treatment of chronic idiopathic urticaria. Chinese Journal of Microbiology & Immunology 2001;21(S:S):56-9. [CENTRAL: CN-00366969]2758194
253. Zhao G, Zhang ZC. Clinical observation of the short-term efficacy of loratadine in the treatment of chronic urticaria (Chinese). Chinese Journal of Dermatology 1994;27(1):65. 2758196
254. Zhi Y, Zhang H, Bi Z. A multicenter, double-blind, randomized, parallel-controlled study on the safety and efficacy of ebastine for the treatment of chronic idiopathic urticaria and allergic rhinitis. Jiangsu Medical Journal 2004;30(3):166-8. [CENTRAL: CN-00497534]2758198
255. Zhou X, Li H, Wang J. Observation of clinical efficacy on treating urticaria with desloratadine and loratadine. Journal of Chongqing Medical University 2003;28(1):78-9. [CENTRAL: CN-00476755]2758200
256. Zuberbier T, Aberer W, Burtin B, Rihoux JP, Czarnetzki BM. Efficacy of cetirizine in cholinergic urticaria. Acta Dermato-Venereologica 1995;75(2):147-9. [MEDLINE: 7604646]2758202
257. Audícana MTLM, Marquina A, Bressieux, JMLF, Valiente R. A double-blind, randomized, dose-ranging trial in four parallel groups of 10, 20 and 30 mg bilastine once daily vs placebo in the symptomatic treatment of chronic idiopathic urticaria (CIU). Journal of Investigational Allergology & Clinical Immunology 2007;17(Suppl 3):77. 2758204
258. Blanca Gomez M, Lopez Perez-Lanzac JC. Chronic idiopathic urticaria: double blind study with H1 plus H2 blockers [Urticaria cronica idiopatica: estudio a doble ciego con bloqueantes H1 mas H2]. Farmacia Clinica 1984;1(7):43-6. [EMBASE: 1984238444]2758206
259. Boggs PB, Ellis CN, Grossman J, Washburne WF, Gupta AK, Ball R, et al. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. Annals of Allergy 1989;63(6 Pt 2):616-20. [MEDLINE: 2574555]2758208
260. Fan XZ, Zhou Y, Liu JX. Efficacy of loratadine in the treatment of chronic urticaria. Shanghai Medical Journal 2000;21(10):25-6. [CENTRAL: CN-00352746]2758210
261. Feng J, Wang J, Yu B, Jia Q, Jin Z, Zhu W, et al. Observation of the efficacy of cetirizine in treatment of chronic and acute urticaria. Chinese Journal of New Drugs 2001;10(8):613-4. [CENTRAL: CN-00382803]2758212
262. Guo YY, Qian JX, Tang Q, Sun ZH. Observation of the therapeutic effect on chronic urticaria treated with compound Fructus Kochiae Scopariae decoction combined with mizolastine. Journal of Clinical Dermatology 2013;42(4):254-6. [EMBASE: 2013380077]2758214
263. Guo XL, Yang WB, Huang FY, Ouyang ZB. Clinical observation on the efficacy of mizolastine and ketotifen for treating chronic urticaria [Chinese]. Journal of Clinical Dermatology 2014;42(11):697-9. [EMBASE: 2014075041]2758216
264. Hatano H, Harada T, Naka W, Hada S, Ishikawa K, Nagashima M, et al. A Double-blind Controlled Study of Azatadine Maleate Tablet (Idulamine) on Urticaria and Pruritus Cutaneus. Rinsho Hyoka (Clinical Evaluation) 1981;9(2):461-99. [CENTRAL: CN-00268275]2758218
265. Monroe EW, Bernstein DI, Fox RW, Grabiec SV, Honsinger RW, Kalivas JT, et al. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Arzneimittel-Forschung 1992;42(9):1119-21. [MEDLINE: 1445478]2758220
266. Okubo Y, Shigoka Y, Yamazaki M, Tsuboi R. Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life. Journal of Dermatological Treatment 2013; Vol. 24, issue 2:153-60. [MEDLINE: 21810005]2758222
267. Sil A, Tripathi SK, Chaudhuri A, Das NK, Hazra A, Bagchi C, et al. Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety. Journal of Dermatological Treatment 2013; Vol. 24, issue 6:466-72. [EMBASE: 2013726800]2758224
268. Tanizaki H, Nakahigashi K, Miyachi Y, Kabashima K. Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. Journal of Dermatological Treatment 2013;24(6):477-80. [EMBASE: 2013726806]2758226
269. Wang AH. Effects of mizolastine vs cyproheptadine in treating chronic urticaria. Journal of Chinese Clinical Medicine 2002;3(17):33-4. [CENTRAL: CN-00451399]2758228
270. Zhang Y, Shang T. Observation of therapeutic effect of mizolastine combined with compound glycyrrhizin in chronic idiopathic urticaria. Journal of Clinical Dermatology 2012;41(11):695-8. [EMBASE: 2013056366]2758230
271. Zhang W, Xu XY, Wang N, Wu SY, Shi Y. Montelukast combined with cetirizine in the treatment of refractory urticaria: a clinical observation [Chinese]. Journal of Clinical Dermatology 2013;42(5):317-8. [EMBASE: 2013442383]2758232
272. Zhu Y. Therapeutic effect and safety of mizolastine in the treatment of urticaria and allergic rhinitis. Journal of Clinical Dermatology 2012;41(11):699-701. [EMBASE: 2013056367]2758234
273. CTRI/2014/04/004545. Comparison of efficacy, safety and cost effectiveness of rupatadine and olopatadine, anti-histaminics, in patient of urticaria. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=8753 (accessed 2 June 2014). 2758236
274. EudraCT: 2004-000771-34. A 6-week multicentre, double-blind, randomised, placebo-controlled, parallel-group study to assess the efficacy and safety of rupatadine 10 and 20 mg in the treatment of chronic idiopathic urticaria (CIU): a phase III clinical trial. clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-000771-34 (accessed 3 July 2013). 2758238
275. EudraCT: 2005-002749-38. A randomized, double-blind, placebo-controlled exploratory trial to evaluate a one-week oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticaria. clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-002749-38 (accessed 3 July 2013). 2758240
276. JPRN-UMIN000001163. Study of optimal treatment duration with antihistamine in idiopathic urticaria patients. www.umin.ac.jp/ctr/index.htm (accessed 24 June 2014). 2758242
277. JPRN-UMIN000003290. Study of the antipruritic effect and onset of sleepiness with oral antihistamines. //www.umin.ac.jp/ctr/index.htm (accessed 24 June 2014). 2758244
278. JPRN-UMIN000008062. A study evaluating efficacy of non-sedative antihistamine up-titration in patients with chronic urticaria who did not respond to standard therapy. www.umin.ac.jp/ctr/index.htm (accessed 24 June 2014). 2758246
279. JPRN-UMIN000008461. A study on the optimal treatment for chronic idiopathic urticaria insufficient for the second-generation antihistamines. www.umin.ac.jp/ctr/index.htm (accessed 24 June 2014). 2758248
280. JPRN-UMIN000010265. Preliminary trial of the increase of antihistamines in dose and a combination of different antihistamine on refractory spontaneous urticaria. www.umin.ac.jp/ctr/index.htm (accessed 24 June 2014). 2758250
281. NCT00199238. A 4-week dose-finding, multicentre, double-blind, randomised, placebo-controlled, parallel-group trial to assess the efficacy and safety of different doses of rupatadine compared to placebo in the treatment of chronic idiopathic urticaria [Efficacy of rupatadine 5, 10 and 20 mg in chronic idiopathic urticaria]. ClinicalTrials.gov/show/NCT00199238 (accessed 3 July 2013). 2758252
282. NCT00199251. Efficacy and safety of rupatadine 10 and 20 mg in chronic idiopathic urticaria. ClinicalTrials.gov/show/NCT00199251 (accessed 3 July 2013). 2758254
283. EudraCT: 2006-001245-33. Double-blind, randomised, placebo-controlled, phase III study comparing the efficacy and safety of bilastine 20 mg once daily and levocetirizine 5 mg for the treatment of chronic idiopathic urticaria [Estudio en fase III, doble ciego, randomizado, controlado con placebo, comparativo de la eficacia y seguridad de bilastina 20 mg una vez al día y levocetirizina 5 mg para el tratamiento de la urticaria crónica idiopática"]. clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-001245-33 (accessed 3 July 2013). 2758256
284. NCT00421109. Efficacy study for the symptomatic treatment of chronic idiopathic urticaria. ClinicalTrials.gov/show/NCT00421109 (accessed 3 July 2013). 2758257
285. NCT00751166. A comparative double-blind, double-dummy study of desloratadine (dl) 5 mg once daily, cetirizine 10 mg once daily, and placebo once daily in patients with chronic idiopathic urticaria (study p03736) (terminated). ClinicalTrials.gov/show/NCT00751166 (accessed 3 July 2013). 2758259
286. NCT00751218. A comparative double-blind, double- dummy study of desloratadine (dl) 5 mg once daily, cetirizine 10 mg once daily, and placebo once daily in patients with chronic idiopathic urticaria (study p03735) (completed). ClinicalTrials.gov/show/NCT00751218 (accessed 3 July 2013). 2758261
287. NCT00783354. A comparison of Aerius continuous treatment versus Aerius prn for chronic idiopathic urticaria (study p03147)(completed). ClinicalTrials.gov/show/NCT00783354 (accessed 3 July 2013). 2758263
288. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema: a review of 554 patients. British Journal of Dermatology 1969;81(8):588-97. [MEDLINE: 5801331]
289. Charlesworth EN. Urticaria and angioedema. Allergy & Asthma Proceedings 2002;23(5):341-5. [MEDLINE: 12476545]
290. Church MK, Maurer M. H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?. Clinical & Experimental Allergy 2012;42(10):1423-9. [PUBMED: 22994340]
291. Demera RS, Ryhal B, Gershwin ME. Chronic idiopathic urticaria. Comprehensive Therapy 2001;27(3):213-7. [PUBMED: 11569322]
292. DuBuske LM. Second-generation antihistamines: the risk of ventricular arrhythmias. Clinical Therapeutics 1999;21(2):281-95. [PUBMED: 10211532]
293. Fedorowicz Z, van Zuuren EJ, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD008596.pub2]
294. Gaig P, Olona M, Munoz Lejarazu D, Caballero MT, Dominguez FJ, Echechipia S, et al. Epidemiology of Urticaria in Spain. Journal of Investigational Allergology & Clinical Immunology 2004;14(3):214-20. [PUBMED: 15552715]
295. Grattan C, Powell S, Humphreys F, British Association of Dermatologists. Management and diagnostic guidelines for urticaria and angio-oedema. British Journal of Dermatology 2001;144(4):708-14. [MEDLINE: 11298527]
296. Grattan CE, Humphreys F, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. British Journal of Dermatology 2007;157(6):1116-23. [MEDLINE: 18021095]
297. Hauser C. Chronic urticaria. Evidence-Based Dermatology. http://www.blackwellpublishing.com/medicine/bmj/dermatology/pdfs/chronic_urticaria.pdf 2003 (accessed December 2004).
298. Hellgren L. The prevalence of urticaria in the total population. Acta Allergologica 1972;27(3):236-40. [MEDLINE: 4678809]
299. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org 2011.
300. Holgate ST, Canonica GW, Simons E, Taglialatela M, Tharp M, Timmerman H, et al. Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clinical & Experimental Allergy 2003;33(9):1305-24. [EMBASE: 2003372691]
301. Humphreys F, Hunter JA. The characteristics of urticaria in 390 patients. British Journal of Dermatology 1998;138(4):635-8. [MEDLINE: 9640369]
302. James WD, Berger TG, Elston DM. Andrews' Diseases of the Skin: Clinical Dermatology. 11th Edition. St Louis: Saunders Elsevier, 2011. [ISBN 1437703143]
303. Kavosh ER, Khan DA. Second-generation H1-antihistimines in chronic urticaria: an evidence-based review. American Journal of Clinical Dermatology 2011;12(6):361-76. [MEDLINE: 21967114]
304. Kozel MMA, Mekkes JR, Bossuyt PMM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. Journal of the American Academy of Dermatology. Mosby, 2001; Vol. 45, issue 3:387-91. [EMBASE: 2001306464]
305. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy: European Journal of Allergy and Clinical Immunology 2011;66(3):317-30. [EMBASE: 2011077490]
306. Maurer M, Bindslev-Jensen C, Gimenez-Arnau A, Godse K, Grattan CEM, Hide M, et al. Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update. British Journal of Dermatology 2013;168(2):455-6. [EMBASE: 2013077748]
307. NCT00264303. CUTE (Chronic Urticaria Treatment Evaluation). //clinicaltrials.gov/show/NCT00264303 (accessed 3 July 2013).
308. Nolen TM. Sedative effects of antihistamines: safety, performance, learning, and quality of life. Clinical Therapeutics 1997;19(1):39-55. [EMBASE: 1997130608]
309. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
310. Sarbijt S. Chronic urticaria: clinical manifestations, diagnosis, pathogenesis, and natural history. www.uptodate.com/contents/chronic-urticaria-clinical-manifestations-diagnosis-pathogenesis-and-natural-history?source=see_link&anchor=H23#H25) (accessed 13 March 2014).
311. Spector SL, Shikiar R, Harding G, Meeves S, Leahy MJ. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis 2007;79(2):157-62. [MEDLINE: 17388220]
312. Zuberbier T. A Summary of the New International EAACI/GA2LEN/EDF/WAO Guidelines in Urticaria. World Allergy Organization Journal 2012;5(Suppl 1):S1-5. [DOI: 10.1097/WOX.0b013e3181f13432]